NewAmsterdam Pharma Co. N.V. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

NewAmsterdam Pharma Co. N.V. (NAMS) — Frequently Asked Questions

NewAmsterdam Pharma Co. N.V. (NAMS) is a publicly traded US company. Explore NAMS's stock price, financial statements, earnings history, margins and key ratios below.

What is the NAMS stock price?

NAMS trades at $29.93 (+2.06% on the day).